Finite mixture varying coefficient models for analyzing longitudinal heterogenous data
Related Experiment Video
Updated: May 26, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
Published on: July 3, 2020
1Department of Statistics, Chinese University of Hong Kong, Shatin, NT, Hong Kong.
Abstract:
This paper aims to develop a mixture model to study heterogeneous longitudinal data on the treatment effect of heroin use from a California Civil Addict Program. Each component of the mixture is characterized by a varying coefficient mixed effect model. We use the Bayesian P-splines approach to approximate the varying coefficient functions. We develop Markov chain Monte Carlo algorithms to estimate the smooth functions, unknown parameters, and latent variables in the model. We use modified deviance information criterion to determine the number of components in the mixture. A simulation study demonstrates that the modified deviance information criterion selects the correct number of components and the estimation of unknown quantities is accurate. We apply the proposed model to the heroin treatment study. Furthermore, we identify heterogeneous longitudinal patterns.
Related Concept Videos
Mechanistic Models: Compartment Models in Individual and Population Analysis
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Methods of Medium Optimization
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
